Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. Abe K, Holmes TH, Nguyen TT, Kim-Schulze S, et al. J Immunol 2025;214:3310-3320.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abe K, Holmes TH, Nguyen TT, Kim-Schulze S, et al. Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. J Immunol 2025;214:3310-3320.
PMID: 41166719